devinitorg/iati-policy-markers huggingface dataset:
NIHR Global Health Research Group on Sepsis A UK and low- and middle-income country (LMIC) partnership that aims to advance a multidisciplinary approach to address the problem of sepsis in sub-Saharan Africa. 1) Sustainably improve sepsis research training. 2) Reach consensus on research priorities and sepsis care quality indicators for Africa. 3) Pilot test innovative sepsis care interventions. 4) Test novel clinical trial platforms to answer key sepsis questions for Africa.


Following a costed extension, additional objectives will include:
Work Package 1 : Extend cohort enrolment by 6-12 months dependent on site.
1. Improve estimate precision of hospital admission over a longer time period.
2. Provide sufficient numbers for investigating post-discharge mortality, morbidity, and re-hospitalisation risk factors.

Work Package 2: Host response to sepsis. Inclusion of transcriptomic or immunological profiles to facilitate patient stratification into subgroups (endotypes).
1. Compare sepsis endotypes between High Income Countries and Low and Middle Income Countries.
2. Develop an accurate temporal association of endotypes and clinical outcomes for patients in Malawi and Uganda.
3. Identify transcriptomic biomarkers for validation of a pan-sepsis prognostic panel.

Work Package 3: Expand the capabilities of the BASIS research network (addition of three countries to the current core sites).
1. Describe important differences in the presenting features of patients with sepsis in African hospitals.

Work Package 4: Refinement of the eSIMS (electronic Severe Illness Management Support) platform.
1. Add functionality informed by the current work.
2. Evaluate whether eSIMS impacts the processes of sepsis care in platform-naïve health facilities
NIHR GRP: Preventing Invasive Salmonella Disease in Africa The NIHR Global Research Professorship scheme is open to all professions and all Higher Education Institutions (HEI), based in England and the Devolved Administrations, to nominate health researchers and methodologists with an outstanding research record of clinical and applied health research and its effective translation for improved health. Global Research Professors are required to have existing strong collaborations or links with collaborators or partners in institutions in countries on the OECD DAC list and the award should plan to strengthen these/support training and capacity development/mentorship in these partners. Typhoid fever and Invasive Non-Typhoidal Salmonella (iNTS) disease are two invasive blood-stream infections caused by bacteria called Salmonella responsible for serious illness and death particularly in young children in sub-Saharan Africa. This research aims to drive translational impact in the prevention of invasive Salmonella disease in Africa, with the major focus on accelerating and advancing the national and regional introduction of vaccination for Typhoid and for iNTS disease. The project is based in Malawi and the majority of the research will be conducted in this region. To accelerate the vaccine prevention of Typhoid fever and Invasive Non-Typhoidal Salmonella disease. The research has 3 workstreams: 1.) Epidemiology: how much typhoid and iNTS disease are happening, and how do they spread in urban and rural communities? 2.) Protection: How do people’s bodies make protective immune responses against Salmonella infection, and how can we design better vaccines? 3.) Vaccines: How well do the vaccines actually work in healthy and immunosuppressed children? In addition Professor Gordon will support these workstreams with activities to discuss and explain Salmonella disease and research among the communities she works with, use research findings to engage with stakeholders and accelerated introduction of vaccines, and train the next generation of doctors and scientists in Malawi to be the researchers of the future.
NIHR HPSR-DA: Addressing Health System Fragmentation to Advance Universal Health Coverage (UHC) for Low Income Populations in Latin America This project strengthens an existing collaboration between UK-Brazil and extends this to other Latin America countries. It will develop a policy-relevant research agenda to understand and address health system inadequacies in the region, including their impact on Universal Health Coverage (UHC). The main output will be a research proposal focused on health system fragmentation in Latin America, which is widespread in the region and has an especially negative impact on the health of low-income populations. To identify policy-relevant evidence gaps for the proposed research programme, we will undertake a needs assessment and research planning in Brazil and two other countries. This will involve: 1) active, fully integrated stakeholder involvement and engagement (involving policy-makers, non-governmental organisations and civil society); 2) a literature review; 3) identification and curation of data sources; 4) formulation of a research team, covering key methodological requirements; 5) capacity building. 1) Develop a research programme proposal focused on health system fragmentation in Latin America Countries. This setting affords valuable learning to policy-makers in many low- and middle-income countries (LMICs) wishing to advance UHC given fragmentation plagues even mature health systems despite policy innovations to address this. To identify policy-relevant evidence gaps for the proposed research programme, we will undertake a needs assessment and research planning in Brazil and two other countries.
NIHR RIGHT 4: A programme for burns management and prevention in low-resource settings in Pakistan A UK and low-and-middle-income-country (LMIC) partnership to address burn management, treatment and prevention in low-resource settings in Pakistan.  Globally, burns are responsible for around 11 million injuries and 180 000 burn-related deaths yearly. Unfortunately, 9 of 10 burn injuries and deaths happen in low-and-middle-income countries (LMICs) such as Pakistan. One in three people admitted to hospitals with burn injuries die within three weeks, and survivors face serious lifelong physical, emotional and social problems.  Current preventive practice and treatment services in Pakistan are lacking for burns-related problems. Therefore, there is an urgent need to improve the quality of health services for burn victims and reduce the rate of burns in Pakistan. The project will be carried out in burn centres and community across Pakistan. The project’s overall aim is to evaluate culturally adapted prevention and multidisciplinary care quality and rehabilitation programmes for burns that can be implemented across LMICs.
The projects objectives are;
1. To understand lived experiences of burn survivors, families, and other stakeholders including the experience of care and impact of burns 
2. To work together with key stakeholders (such as burn survivors, family members) to adapt a culturally appropriate affordable burn rehabilitation programme 
3. To develop a national burn registry that will help to collect information on burn injuries and after-effects 
4. To carry out a small-scale study to assess whether the co-adapted burn rehabilitation programme is feasible and acceptable in Pakistan. This will help the research team to prepare themselves for a larger study particularly on the aspects around how best to recruit and retain burn survivors in the study.
5. To determine clinical effectiveness of the burn rehabilitation programme. This will be evident from changes in number of deaths caused by burn injuries, number of burn survivors readmitted to hospitals and impact on burn survivors’ health-related of quality life 
6. To determine whether the proposed burn rehabilitation programme is effective/valuable in relation to its cost.
7. To undertake social media campaigns to promote burn prevention and risk assessment in communities, workplaces, industries, and households,  improve first aid and address burn related stigma 
8. To work with policy makers and parliamentarians to develop national guidelines for burns care and prevention in Pakistan 
9. To build the capacity and capability of researchers and health professionals both in research and clinical practice. 
These activities are crucial to improve prevention and burn rehabilitation across the country after the end of the project.
Coalition for Epidemic Preparedness Innovations (CEPI) - Development of vaccines against diseases with epidemic potential The Coalition for Epidemic Preparedness Innovations (CEPI) was formally launched at the World Economic Forum in Davos in January 2017. It is the only international alliance with a primary focus on developing vaccines for diseases with epidemic potential. CEPI’s initial focus has been on developing vaccines against Lassa Fever, Nipah virus and Middle Eastern Respiratory Syndrome (MERS) virus. The aim is to fund and to support the research and development of vaccines for diseases with epidemic potential. 
Preparedness:
 - Advance access to safe and effective vaccines against emerging infectious diseases 
Response: 
 - Accelerate the research, development and use of vaccines during outbreaks 
Sustainability:
 -  Create durable and equitable solutions for outbreak response capacity
NIHR-Wellcome Global Health Research Partnership This partnership between the UK’s National Institute for Health and Care Research (NIHR) and Wellcome funds global health researchers who focus on health priorities in low- and middle-income countries. The aim of the partnership between DHSC Global Health Research and Wellcome is to support high quality applied global health research in areas of mutual interest, with the following components: 
1. Develop and deliver a portfolio of Fellowships for applicants from low and middle-income countries (LMICs) using the established Wellcome Trust International Fellowship scheme, expanding this to encourage applications in targeted areas where skills shortages have been identified, which align with the priority areas of DHSC global health research and Wellcome and where there is an identified need to build research capability (skills gap). The first areas under discussion are global mental health, non-communicable diseases, snake bite and multimorbidity.
2. Support Major Awards in eligible global health research areas (through Collaborative Awards, Investigator Awards and Senior Research Fellowship schemes) in collaboration with the Wellcome Science Division where NIHR co-funds a small number of joint NIHR-Wellcome awards (50:50) in strategically relevant areas. 
3. Support a policy-uptake initiative with Wellcome Global Health Policy to facilitate global health research uptake into policy and practice.
NIHR HPSR-CA: Learning to Harness Innovation in Global Health for Quality Care (HIGH-Q) Essential technologies could improve quality and outcomes of care if they are successfully adopted but benefits in poorer countries are threatened by workforce shortages and a failure to consider all the obstacles to their use up and down the system. Thus, many technologies fail, for example it is reported there are over 200,000 failed mHealth apps. This wastes valuable resources, or can even worsen care quality. Our proposal addresses this key emerging issue in Kenya. In doing this we address the priority areas of Quality of Care, including families’ experiences of care; Health Workforce Management and Planning, as we explore how technologies can support or undermine routine work in settings with few staff; and Integrating Health Services & Improved Data Quality and Use, by exploring how information technologies might best support post-discharge care for sick babies.This research has the direct and primary aim of improving the health, wellbeing and economic development of people in low and middle income countries. We have two broad objectives: 
1. To learn how technologies can be better designed and introduced in weak health systems to yield benefits and reduce harms and waste.
2. To build capacity of government and researchers for these difficult but important evaluations so they help poorer countries strengthen their health systems.
To achieve these in Work-package 1 we will design and conduct an evaluation using multiple approaches of a large existing hospital technology intervention programme. We will deliberately change staff numbers to explore how this affects quality and technology adoption. In Work-package 2, we focus on using methods that involve staff and families to co-design an approach that helps schedule the care sick babies need after hospital discharge and ensures all health staff and families have access to key information needed for follow up care. This work will produce an outline technology for testing with new funding. In Work-package 3 we tackle cross-cutting issues including how technologies are changing the jobs people do and the skills they need individually and as teams to give quality care and explore what oversight mechanisms are needed to gain good evidence on the effects of introducing technologies in health.
Royal Society of Tropical Medicine and Hygiene Early Career Grants Scheme 2023-2025 A partnership with the Royal Society of Tropical Medicine and Hygiene (RSTMH) to support small grant awards for early career researchers based in low- and middle-income countries (LMICs). Awards will specifically support research and capacity development for LMIC researchers which will benefit patients and the public in LMICs The 2023-2025 rounds of the RSTMH Early Career Grants programme will: 
1) enable early career researchers and global health professionals of LMIC nationality to undertake applied health research or fieldwork that directly and primarily benefits people in LMICs 
2) develop and improve the research and management skills of early career LMIC researchers through leading a small independent research project 
3) help early career LMIC researchers to widen their networks within their institutions, countries and potentially globally, and within their field of work
4) establish a peer cohort of awardees to increase collaboration and networking opportunities 
5) support early career LMIC researchers to progress their careers
6) strengthen a beneficial scheme to ensure that a higher proportion of fundable applications receive funding than previous years
European and Developing Countries Clinical Trials Partnership (EDCTP) phase III: The Global Health The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The European and Developing Countries Clinical Trials Partnership (EDCTP) funds clinical research to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.  This activity is a component of European and Developing Countries Clinical Trials Partnership (EDCTP) phase III (Global Health EDCTP3) programme (A7397_AA7398). DHSC will support EDCTP3 activities in the fiscal year 2024-2025, which supports relevant Global Health EDCTP3 call topics and capacity strengthening under  agreed work programmes. Possible call topic areas include neglected tropical diseases, vector control, digital health and research training fellowships.
NIHR HPSR-DA: Collaborative partnerships addressing the effects of urban violence on youth access to health services in South Africa and Brazil This project will build partnerships towards developing selected health system interventions to address the impact of urban violence on youth access to health services in South Africa and Brazil. The objectives are: 1) Build collaborations with South Africa and Brazil, as countries affected by urban violence particularly in low-income neighbourhoods 2) Carry out a scoping review of the evidence on the influence of urban violence on treatment seeking and health systems and interventions to address this 3) Engage with stakeholders in local health services and socio-economic development, and youth in affected communities, to increase understanding of health systems issues and interventions to decrease the impact of urban violence on youth healthcare access 4) Through collaborative partnerships, work towards developing context appropriate specific health systems micro and meso interventions in South Africa and Brazil for proof-of-concept testing in a future proposal 1) Develop a collaboration between University partners in UK, South Africa and Brazil who together have expert knowledge and/or experience in violence, health systems research, health policy and public engagement.
2) Carry out a scoping review of the evidence on urban violence’s influence on treatment seeking and health systems and potential interventions that may help.
3) Engage with multilevel stakeholders in different sectors in Cape Town, São Paulo and Porto Alegre to identify health systems-related issues and possible interventions. This will include developing an advisory group in each site as well as interviews and workshops with youth groups and healthcare providers in affected communities, health and development policy makers and non-governmental organisations
4) Develop further research plans for a proof-of-concept intervention study to see if the interventions would be feasible and could work. This would include both social and health system elements.
Foundation for Innovative New Diagnostics The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provided support to the Foundation for Innovative New Diagnostics (FIND) for the development of critical diagnostic assays for prioritised Target Product Profiles (TPPs) using innovative technology platforms and business models. Develop critical diagnostic assays for prioritised Target Product Profiles (TPPs) using innovative technology platforms and business models.
Research to improve adolescent health in Low and Middle Income Countries: Call 4 The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). This programme is administered by the UK Medical Research Council (MRC), which reports activities under the UK Department for Business, Energy and Industrial Strategy (BEIS). NIHR disburses funds to MRC, which makes onwards disbursements to awardees. This initiative funds research grants to improve adolescent health in low- and middle-income countries (LMICs). This call seeks to provide the research evidence needed to effect real and practical changes to improve adolescent health in low- and middle-income countries (LMICs).
Awards should be genuine interdisciplinary collaborations across social science, biomedical science and other disciplines including health economics and political science. The following thematic area are of particular focus:
-research in conflict-affected and fragile states;
-road traffic and other injuries;
-prevention of interpersonal violence;
-self-harm (including suicide);
-lower respiratory tract infections such as pneumonia;
-prevention and treatment of substance use (alcohol, tobacco and other drugs);
-future Non-Communicable Disease (NCD) risk factors (raised blood pressure, raised blood glucose, obesity and smoking);
-nutrition, diet and physical activity;
-disabilities - mental, intellectual, and physical;
-the transition out of adolescence into adulthood, including the transition to adult services;
-research addressing social (and commercial) determinants of health.
NIHR Global Health Research Unit on Lung Health and Tuberculosis in Africa A UK and low- and middle-income country (LMIC) partnership that aims to improve the health of children and adults through multi-disciplinary applied health research on lung health and tuberculosis, including non-communicable lung diseases and acute presentations of lung disease. This research has the direct and primary aim of improving the health, wellbeing and economic development of people in LMICs. 1) To focus their research efforts on improving lung health and fighting TB in Africa.  2) To support scientists and work to strengthen the research infrastructure of their institutions. 3) To conduct collaborative research to fill gaps in the current evidence base. For example, to explore ways to bring basic effective and affordable care to people living in both remote rural areas and expanding cities and slums. 4) To develop a 10 to 20 year strategy for Unit-led applied global health research in lung health and TB to look well beyond the initial funding with their sights set on delivering improvements in health for Africa's poorest populations.
Research to Improve Adolescent Health in Low- and Middle-Income Country (LMIC) Settings: call 2 The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). This programme is administered by the UK Medical Research Council (MRC), which reports activities under the UK Department for Business, Energy and Industrial Strategy (BEIS). NIHR disburses funds to MRC, which makes onwards disbursements to awardees. This activity is a component of the Applied Research for Adolescent Health in Low and Middle Income Countries  programme (GB-GOV-10-Adol_Health). This initiative funds research grants to improve adolescent health in low- and middle-income countries (LMICs). 1 ) Fund high-quality research to address major health issues that emerge at the adolescent phase of life; 2) Provide the research evidence needed to effect real and practical changes to improve adolescent health in Low- and Middle-Income Countries (LMICs); 3) Encourage genuine interdisciplinary collaborations across social science, biomedical science and other disciplines including health economics and political science; 4) Support capacity building in research; 5) Encourage equitable partnerships with, and scientific leadership from, LMIC investigators.
NIHR Global Health Research Unit on Respiratory Health (RESPIRE) A UK and low- and middle-income country (LMIC) partnership that aims to improve respiratory outcomes from common respiratory communicable and non-communicable disorders. This research has the direct and primary aim of improving the health, wellbeing and economic development of people in LMICs. 1) To build on their track-record of epidemiological research and capacity development in LMIC. 2) To invest in and strengthen our existing collaborations with leading research groups in South Asia. 3) To leverage their critical mass in respiratory, informatics and health services research, to expand efforts into the neglected field of applied respiratory research. 4) Build a network of laboratories and experts across strategically important countries from which to expand to similar local contexts elsewhere.